Anti-REDD2 antibodies enable researchers to detect and measure the REDD2 antigen in biological samples. This target is a reported synonym of the DDIT4L gene, which encodes DNA damage inducible transcript 4 like. This protein is reported to inhibit cell growth by regulating the TOR signaling pathway upstream of the TSC1-TSC2 complex and downstream of AKT1. The human version of REDD2 has a canonical amino acid length of 193 residues and a protein mass of 21.7 kilodaltons. It is reported to be localized in the cytoplasm of cells. Other names for this target antigen include DNA damage-inducible transcript 4-like protein, HIF-1 responsive protein RTP801-like, and REDD-2. Indicated applications for REDD2 antibodies listed below include ELISA, Western Blot, and Immunohistochemistry.